Targeted cancer therapy (antibody-drug conjugate)
Last reviewed April 2026
Who is this for?
Trastuzumab emtansine (sold as Kadcyla in Nigeria) is a targeted cancer medicine that combines an antibody with a powerful chemotherapy drug. It attaches specifically to HER2 protein on certain breast cancer cells and delivers the chemotherapy directly into those cells, killing them while sparing most healthy cells.
Prescription Required
You need a doctor's prescription to buy this drug.
Explore this drug